Key statistics
On Wednesday, Armata Pharmaceuticals Inc (TG1N:FRA) closed at 2.16, 22.03% above the 52 week low of 1.77 set on Nov 22, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.06 |
---|---|
High | 2.16 |
Low | 2.06 |
Bid | 2.02 |
Offer | 2.12 |
Previous close | 2.14 |
Average volume | 14.67 |
---|---|
Shares outstanding | 36.18m |
Free float | 10.77m |
P/E (TTM) | -- |
Market cap | 83.58m USD |
EPS (TTM) | -1.95 USD |
Data delayed at least 15 minutes, as of Oct 09 2024 14:31 BST.
More ▼
Press releases
- Armata Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
- Armata Pharmaceuticals Announces Presentation at the 2024 Military Health System Research Symposium
- Armata Pharmaceuticals Announces Appointment of Life Sciences Accounting and Finance Veteran David House as SVP of Finance and Principal Financial Officer
- Armata Pharmaceuticals Announces Second Quarter 2024 Results and Provides Corporate Update
- Armata Pharmaceuticals Receives $5.25 Million of Additional Non-Dilutive Grant Funding from the U.S. Department of Defense to Support Ongoing diSArm Clinical Trial of AP-SA02
More ▼